4//SEC Filing
Wang Xiaolin 4
Accession 0001567619-21-017415
CIK 0001628171other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 7:47 PM ET
Size
4.9 KB
Accession
0001567619-21-017415
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2021-09-17$30.02/sh−250$7,505→ 12,195 total
Footnotes (2)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Includes 9,800 RSUs.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001849181
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 7:47 PM ET
- Size
- 4.9 KB